Gut microbiota constitute the largest reservoir of the human microbiome and are an
abundant and stable ecosystem—based on its diversity, complexity, redundancy, and host …

The gut bacterial microbiome, particularly its role in disease and inflammation, has gained
international attention with the successful use of fecal microbiota transplantation (FMT) in the …

The aetiology of inflammatory bowel disease (IBD) probably involves a combination of
genetic predisposition and environmental factors that may be channelled through an …

Gut dysbiosis is a characteristic of inflammatory bowel disease (IBD) and is believed to play
a role in the pathogenesis of IBD. Fecal microbiota transplantation (FMT) is an effective …

The building evidence for the contribution of microbiota to human disease has spurred an
effort to develop therapies that target the gut microbiota. This is particularly evident in …

The human body is home to a variety of micro-organisms. Most of these microbial
communities reside in the gut and are referred to as gut microbiota. Over the last decades …

Background The interplay between host genetics, immunity, and microbiota is central to the
pathogenesis of inflammatory bowel disease. Previous population-based studies suggested …

The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota
composition and function, is associated with gastrointestinal disorders, including …

Background and aims Bacteriotherapy aimed at addressing dysbiosis may be therapeutic for
Inflammatory Bowel Diseases (IBDs). We sought to determine if defined Bacteroides-based …

Background & Aims Fecal microbiota transplantation (FMT) is an emerging treatment
modality for ulcerative colitis (UC). Several randomized controlled trials have shown efficacy …